Effects of Camel Milk on Antioxidant Activity in Rats with Valproic Acid-induced Autism

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 247

This Paper With 11 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JNFH-9-2_011

تاریخ نمایه سازی: 20 تیر 1400

Abstract:

Introduction: Autism spectrum disorder refers to a wide range of nervous system disorders. Autistic patients often have a defective antioxidant defense system and manifest symptoms of impaired cognitive interaction. Camel milk has numerous beneficial nutrients and has been used in the treatment of autism. The present study aimed to investigate the effects of camel milk on the antioxidant activity and enzymes of autistic rats. Methods: Pregnant rats were intraperitoneally injected on embryonic day ۱۲.۵ with valproic acid (VPA; ۵۰۰ mg/kg) to induce an autistic state. In addition, ۱۸ male offspring rats were injected with risperidone (۰.۲ mg/kg) three times per week. Six of these cases were fed daily with raw camel milk (۱۰ ml/kg), and six others were fed with pasteurized camel milk for ۴۲ days. Social interaction and repetitive behaviors were measured using the Y-maze based on catalase (CAT) activity, glutathione (GSH) level, and superoxide dismutase (SOD) activity at the outset and after the treatment period. Results: Behavioral symptoms (impaired social interaction and repetitive behaviors) were evident after VPA administration. After receiving treatment, impaired social interaction and repetitive behaviors significantly improved in the autistic rats (P<۰.۰۱). In addition, VPA enhanced the oxidative stress status in the biochemical tests (P<۰.۰۰۱), and camel milk increased CAT activity (P<۰.۰۰۱), GSH level (P<۰.۰۵), and SOD activity (P<۰.۰۰۰۱). Conclusion: According to the results, camel milk could recover the VPA-induced impairment of social interaction and repetitive behaviors in the autistic rats and improve the defects in their antioxidant defense system.

Authors

Sahar Heydari

Department of Physiology and Pharmacology, Faculty of Medicine, Sabzevar University of Medical Sciences, Iran

Ali Mahmoudi

Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Iran

Bahareh Amin

Associate Professor of Department of Physiology and Pharmacology, Faculty of Medicine, Sabzevar University of Medical Sciences, Iran

Akbar Pejhan

Department of Physiology and Pharmacology, Faculty of Medicine, Sabzevar University of Medical Sciences, Iran

Seyed Jamal Mirmoosavi

Department of Traditional Medicine, School of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran

Omid Gholami

Department of Physiology and Pharmacology, Faculty of Medicine, Sabzevar University of Medical Sciences, Iran

Mohammad Mohammad-Zadeh

Psychiatry &amp; Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Jones EJ, Gliga T, Bedford R, Charman T, Johnson MH. ...
  • ۲.Bromley RL, Mawer G, Clayton-Smith J, Baker GA. Autism spectrum ...
  • ۳.Yenkoyan K, Grigoryan A, Fereshetyan K, Yepremyan D. Advances in ...
  • ۴.Rodier PM. Animal model of autism based on developmental data. ...
  • ۵.Roullet FI, Lai JK, Foster JA. In utero exposure to ...
  • ۶.Karl T, Pabst R, von Hörsten S. Behavioral phenotyping of ...
  • ۷.Mirza R, Sharma B. Benefits of Fenofibrate in prenatal valproic ...
  • ۸.Stepanova E, Dowling S, Phelps M, Findling RL. Pharmacotherapy of ...
  • ۹.Dolske MC, Spollen J, McKay S, Lancashire E, Tolbert L. ...
  • ۱۰.Liguori I, Russo G, Curcio F, Bulli G, Aran L, ...
  • ۱۱.Rose S, Melnyk S, Pavliv O, Bai S, Nick TG, ...
  • ۱۲.James SJ, Melnyk S, Jernigan S, Pavliv O, Trusty T, ...
  • ۱۳.Manivasagam T, Arunadevi S, Essa MM, SaravanaBabu C, Borah A, ...
  • ۱۴.Russo AJ. Decreased serum Ou/Zn sOD in children with Autism. ...
  • ۱۵.Al-Ayadhi LY, Elamin NE. Camel milk as a potential therapy ...
  • ۱۶.Yagil R. Camel milk and its unique anti-diarrheal properties. Isr ...
  • ۱۷.Mohamed HE, Mousa HM, Beynen AC. Ascorbic acid concentrations in ...
  • ۱۸.Ambali SF, Idris SB, Onukak C, Shittu M, Ayo JO. ...
  • Clutton-Brock J. A natural history of domesticated mammals: Cambridge University ...
  • ۲۰.Saltanat H, Li H, Xu Y, Wang J, Liu F, ...
  • ۲۱.Shabo Y, Yagil R. Etiology of autism and camel milk ...
  • ۲۲.Adams CM. Patient report: autism spectrum disorder treated with camel ...
  • ۲۳.Hara Y, Ago Y, Higuchi M, Hasebe S, Nakazawa T, ...
  • ۲۴.Wang L, Almeida LE, Spornick NA, Kenyon N, Kamimura S, ...
  • ۲۵.Merali Z, Presti-Torres J, Mackay JC, Johnstone J, Du L, ...
  • ۲۶.Madesh M, Balasubramanian KA. Microtiter plate assay for superoxide dismutase ...
  • ۲۷.Aebi H. Catalase in vitro. Methods Enzymol. ۱۹۸۴;۱۰۵:۱۲۱-۶ ...
  • ۲۸.Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. ۱۹۵۹;۸۲(۱):۷۰-۷ ...
  • ۲۹.Hamzawy MA, El-Ghandour YB, Abdel-Aziem SH, Ali ZH. Leptin and ...
  • ۳۰.Silverman JL, Pride MC, Hayes JE, Puhger KR, Butler-Struben HM, ...
  • ۳۱.Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, ...
  • ۳۲.Schneider T, Turczak J, Przewłocki R. Environmental enrichment reverses behavioral ...
  • ۳۳.Ishola IO, Balogun AO, Adeyemi OO. Novel potential of metformin ...
  • ۳۴.Kumar H, Sharma BM, Sharma B. Benefits of agomelatine in ...
  • ۳۵.Al-Amin MM, Rahman MM, Khan FR, Zaman F, Mahmud Reza ...
  • ۳۶.Hara Y, Ago Y, Taruta A, Hasebe S, Kawase H, ...
  • ۳۷.Kawanai T, Ago Y, Watanabe R, Inoue A, Taruta A, ...
  • ۳۸.Sharp JA, Brennan AJ, Polekhina G, Ascher DB, Lefevre C, ...
  • ۳۹.Banerjee A, García-Oscos F, Roychowdhury S, Galindo LC, Hall S, ...
  • ۴۰.Fleming SA, Mudd AT, Hauser J, Yan J, Metairon S, ...
  • ۴۱.Caiati MD, Cherubini E. Fluoxetine impairs GABAergic signaling in hippocampal ...
  • ۴۲.Bernal-Morales B, Cueto-Escobedo J, Guillén-Ruiz G, Rodríguez-Landa JF, Contreras CM. ...
  • ۴۳.Matsuo K, Yabuki Y, Fukunaga K. ۵-aminolevulinic acid inhibits oxidative ...
  • ۴۴.Win-Shwe TT, Nway NC, Imai M, Lwin TT, Mar O, ...
  • ۴۵.Abd-Elhakim YM, El-Sharkawy NI, Mohammed HH, Ebraheim LLM, Shalaby MA. ...
  • ۴۶.Ibrahim HM, Mohammed-Geba K. Camel milk exosomes modulate cyclophosphamide-induced oxidative ...
  • ۴۷.Zibaee S, Hosseini SM, Yousefi M, Taghipour A, Kiani MA, ...
  • ۴۸.Malaguarnera M, Khan H, Cauli O. Resveratrol in autism spectrum ...
  • ۴۹.Stojković T, Radonjić NV, Velimirović M, Jevtić G, Popović V, ...
  • نمایش کامل مراجع